Gonorrhea is on the rise in the U.S. (Photo: Getty Images) Cases of gonorrhea are skyrocketing in the U.S. after hitting a historic low in 2009. In 2020 (the most recent year data is available), more ...
As drug-resistant gonorrhea rapidly spreads around the world, one team of researchers may have a strategy to combat it, according to a new study. Gonorrhea is becoming a superbug, meaning the drugs ...
Experts say that overuse of antibiotics has led to antibiotic-resistant gonorrhea. (Getty Images) That’s concerning given that almost half of U.S. gonorrhea infections in 2022 were resistant to at ...
You never want to see the words "gonorrhea" and "super" in the same sentence, such as "super, you have gonorrhea" or "gonorrhea is super." However, "super" gonorrhea is becoming an increasing reality ...
11monon MSN
Chlamydia and Gonorrhea Warning for New York
"Getting tested for STIs on a regular basis is an important action that all New Yorkers can take to optimize their health," ...
You may have heard recently that drug-resistant gonorrhea is out there, which is sufficiently terrifying news. That news comes courtesy of the World Health Organization, which released a report last ...
When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. The sexually transmitted disease gonorrhea is becoming increasingly more difficult, or at times ...
Gonorrhea may soon become untreatable. The Centers for Disease Control and Prevention reported Thursday that the wily Neisseria gonorrhoeae bacteria may be developing resistance to the only two ...
Gonorrhea has taken many forms over the last few decades. The strain that people acquire today isn’t the same one that previous generations had to deal with. In fact, it might not be the same strain ...
Drug-resistant gonorrhea is becoming more common, making a once easily treated infection into a nightmare disease, the World Health Organization said Friday. Gonorrhea, known commonly as "the clap" or ...
The FDA’s docket in December includes decisions for two big biologic franchises: BMS’s Breyanzi and Amgen’s Uplizna.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback